Search Results

FDA Approves Indication for Medtronic's Valiant Captivia to Treat Type B Aortic Dissections

January 28, 2014—Medtronic, Inc. (Santa Rosa, CA) announced it has received approval from the US Food and Drug Administration (FDA) for the Valiant Captivia thoracic stent graft system to be used in the treatment of type B aortic dissections.

Conformable Gore TAG's FDA Approval Becomes First to Include Endovascular Repair of Aortic Dissection

September 11, 2013—Gore & Associates (Flagstaff, AZ) has announced that the US Food and Drug Administration (FDA) approval for the company's Conformable Gore TAG thoracic endoprosthesis now includes endovascular repair of acute and chronic type B dissections of the descending thoracic aorta.

Medtronic Introduces Aortic and Peripheral Devices in the United States

June 4, 2014—Medtronic, Inc. announced the market expansion of two recently US Food and Drug Administration (FDA)-approved devices.

Terumo Aortic Launches EXTEND Global Postapproval Study for Thoraflex Hybrid

June 13, 2023—Terumo Aortic announced the launch of the EXTEND global postapproval study for the company’s Thoraflex Hybrid frozen elephant trunk (FET) device.

Medtronic’s Valiant Captivia TEVAR Device to Treat Acute Complicated TBAD Evaluated at 5-Year Follow-Up

May 12, 2020—Online in Journal of Thoracic and Cardiovascular Surgery (JTCVS), Joseph E. Bavaria, MD, et al reported the 5-year outcomes of thoracic endovascular aortic repair (TEVAR) of complicated acute type B aortic dissection (TBAD) in the DISSECTION trial.

Early Results Presented at STS for Gore's Thoracic Single Side Branch Endograft

January 27, 2015—A novel approach for treating thoracic aortic aneurysms was presented at the 51st Annual Meeting of the Society of Thoracic Surgeons (STS), the society announced.